Address book
Contacts
CHIARA BOLEGO
Position
Professoressa Associata
Address
VIA F. MARZOLO, 5 - PADOVA
Telephone
0498275101
EDUCATION and RESEARCH EXPERIENCE
1998-2007 Research Associate, Department of Pharmacological Sciences, University of Milan
1998 Research Fellow,Institute of Arteriosclerosis Research, University of Münster, Germany
1997 PhD in Pharmacology of Natural Compounds, University of Milan
1994 Master Degree in Pharmacology, University of Milan
1992 Research Fellow, Walter Straub Institute of Pharmacology University of Munich, University of Munich
1991 Master Degree in Pharmacy, University of Padua
FELLOWSHIPS
1991-1992: Winner of a grant from the University of Padova for a fellowship at the Institute of Pharmacology in Munich, Germany
1992-1993: Winner of a fellowship from the University of Milan to attend the Graduate School in Pharmacology
1997: Winner of a grant from the Nutrition Foundation of Italy
1998: Fellowship at the Institute of Arteriosclerosis Research, University of Münster, Germany
1998-1999: Post-doctoral fellowship, University of Milan
2001-2002: Winner of a fellowship from the Nutrition Foundation of Italy
1998: Best abstract prize, 70th Congress of the European Atherosclerosis Society
Travel grants from the Italian Pharmacological Society to attend the 38th and 39th National Congresses
2003-2006: Post-doctoral research fellowships from the Institute of Pharmacological Sciences, University of Milan
2006-2007: Post-doctoral research fellowship funded by the EICOSANOX Consortium.
POSITIONS AND EMPLOYMENT
2014-present Associate Professor of Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Padua
2007- 2014 Assistant Professor of Pharmacology, Department of Pharmacology, University of Padova
February-August 2010: Visiting Scientist, Diabetes and Obesity Center of Excellence, Seattle, WA, USA
2017 December: Abilitazione Scientifica Nazionale for Full Professor sector 05/G1 PHARMACOLOGY, CLINICAL PHARMACOLOGY AND PHARMACOGNOSY
EDITORIAL ACTIVITY
Reviewer for several international Journals. Member of PLOs ONE and Frontiers in Pharmacology Editorial board
TEACHING ACTIVITY
2013-now Undergraduate Course at Master Degree in Pharmacy (Pharmacogenetics and Pharmacogenomics), University of Padua
2007-now Undergraduate Course at Master Degree in Pharmaceutical Biotechnology (Molecular Pharmacology), University of Padua
1998 and 2001 Contract Professor, Postgraduate School of Pharmacology, University of Milan
RESEARCH ACTIVITY
Author of 61 publications in international, peer-reviewed journals (h index: 23)
2 book chapters; 2 Congress Proceedings
Complete list of publications: https://www.scopus.com/results/results.uri?sort=plf-f&src=s&st1=bolego&st2=chiara&nlo=1&nlr=20&nls=count-f&sid=3d2e00350b23d19315e654d525bc665c&sot=anl&sdt=aut&sl=34&s=AU-ID%28%22Bolego%2c+Chiara%22+6602842576%29&txGid=afbbf63f2da4b7646214ac807ffc7375
Notices
Office hours
Friday from 16:00 to 17:00
at Studio del docente
Teachings
- PHARMACOGENETICS AND PHARMACOGENOMICS: PRINCIPLES OF PERSONALIZED MEDICINE, AA 2024 (MEQ3103847)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2024 (MEP5070476)
- PHARMACOGENETICS AND PHARMACOGENOMICS: PRINCIPLES OF PERSONALIZED MEDICINE, AA 2023 (MEQ3103847)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2023 (MEP5070476)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2022 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2021 (MEP3051891)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2021 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2020 (MEP3051891)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2020 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2019 (MEP3051891)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2019 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2018 (MEP3051891)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2018 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2017 (MEP3051891)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2017 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2016 (MEP3051891)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2016 (FAM0019595)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2016 (MEP5070476)
- PHARMACOGENETIC AND PHARMACOGENOMIC, AA 2015 (MEP3051891)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2015 (FAM0019595)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2015 (MEP5070476)
- BASIC BIOLOGY AND THERAPEUTIC POTENTIALITY OF STEM CELLS, AA 2014 (FAL1000636)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2014 (FAM1026961)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2014 (FAM0019595)
- BASIC BIOLOGY AND THERAPEUTIC POTENTIALITY OF STEM CELLS, AA 2013 (FAL1000636)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2013 (FAM1026961)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2013 (FAM0019595)
- BASIC BIOLOGY AND THERAPEUTIC POTENTIALITY OF STEM CELLS, AA 2012 (FAL1000636)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2012 (FAM1026961)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2012 (FAM0019595)
- BASIC BIOLOGY AND THERAPEUTIC POTENTIALITY OF STEM CELLS, AA 2011 (FAL1000636)
- MOLECULAR AND EXPERIMENTAL PHARMACOLOGY, AA 2011 (FAM1026961)
- FROM BENCH TO MARKET: THE WAY AHEAD TO DEVELOP NEW MEDICINES, AA 2011 (FAM0019595)
Publications
Author of 61 publications in international, peer-reviewed journals (h index: 23)
2 book chapters; 2 Congress Proceedings
Complete list of publications: https://www.scopus.com/results/results.uri?sort=plf-f&src=s&st1=bolego&st2=chiara&nlo=1&nlr=20&nls=count-f&sid=3d2e00350b23d19315e654d525bc665c&sot=anl&sdt=aut&sl=34&s=AU-ID%28%22Bolego%2c+Chiara%22+6602842576%29&txGid=afbbf63f2da4b7646214ac807ffc7375
Research Area
Sex differences and role of estrogens and selective estrogene receptor modulators in the setting of cardiovascular and chronic inflammatory diseases
Role of drugs and female hormones on functional polarization of human monocytes and macrophages
Role of arachidonic acid metabolites including resolvins in the setting of cardiovascular and chronic inflammatory diseases; pharmacological modulation by COXIBs, aspirin and novel molecules (dual antagonists)